Sarenac Tomislav, Bečić Turkanović Anela, Ferme Peter, Gračner Tomaž
Department of Ophthalmology, University Medical Center Maribor, Ljubljanska 5, 2000 Maribor, Slovenia.
Faculty of Medicine, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia.
J Clin Med. 2022 Jul 4;11(13):3879. doi: 10.3390/jcm11133879.
Presently, there is no efficacious treatment for glaucomatous optic neuropathy; the current treatment is focused on lowering intraocular pressure (IOP). Studies have demonstrated the safety and efficacy of selective laser trabeculoplasty (SLT) in reducing the IOP in eyes with open-angle (OAG) glaucoma or ocular hypertension (OH). Moreover, the European Glaucoma Society has instated SLT as the first-line or adjunctive treatment in OAG or OH, reiterating its clinical significance. In this review, we outline the old and the new roles of SLT, with an emphasis on clinical practice, and look further into its renewed appeal and future developments.
目前，尚无针对青光眼性视神经病变的有效治疗方法；当前的治疗重点是降低眼压（IOP）。研究已证明选择性激光小梁成形术（SLT）在降低开角型青光眼（OAG）或高眼压症（OH）患者眼压方面的安全性和有效性。此外，欧洲青光眼协会已将SLT定为OAG或OH的一线或辅助治疗方法，重申了其临床意义。在本综述中，我们概述了SLT的新旧作用，重点关注临床实践，并进一步探讨其新的吸引力和未来发展。
